TROV Market Cap History
Below is a table of the TROV market cap history going back to 6/4/2018:

Date TROV Market Cap
6/4/201812.32M
7/31/201813.80M
10/31/201816.09M
2/20/201911.07M
4/30/201918.31M
7/31/20199.53M
9/27/20165.55M
10/31/201914.01M
2/20/202017.25M

Also see: TROV Shares Outstanding History
and TROV YTD Return
TROV Historical Market Cap:
+21.70% CAGR
TROV Historical Market Cap: +21.70% CAGR

Mouse over chart for data details
6/4/20187/31/201810/31/20182/20/20194/30/20197/31/20199/27/201610/31/20192/20/2020
TrovaGene is a clinical-stage, oncology therapeutics company, taking a precision medicine approach to develop targeted therapies for the treatment of patients with leukemias, lymphomas and solid tumor cancers. Co.'s drug candidate, onvansertib, is an oral and highly-selective Polo-like Kinase 1 (PLK1) adenosine triphosphate competitive inhibitor. PLK1 is essential for regulating the cell division and maintaining genome stability in mitosis (cell division), spindle assembly, and DNA damage response. Co.'s intellectual property and proprietary technology enables it to analyze circulating tumor DNA and clinically actionable markers for predicting response to cancer therapies. We show 9 historical shares outstanding datapoints in our TROV shares outstanding history coverage, used to compute TROV market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing TROV market cap history over the course of time is important for investors interested in comparing TROV's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of TROV versus a peer is one thing; comparing TROV market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like TROV can fluctuate over the course of history. With this page we aim to empower investors researching TROV by allowing them to research the TROV market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for TROV:
TROV SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
TrovaGene (TROV) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

TRVN Market Cap History
TSRO Market Cap History
TTNP Market Cap History
TTOO Market Cap History
TTPH Market Cap History
TVTY Market Cap History
TXMD Market Cap History
TYME Market Cap History
UHS Market Cap History
USPH Market Cap History
More Healthcare companies »

 

TROV Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.